Insider · CIK 0001837374
Jill Leversage
Files at AUPH (Aurinia Pharmaceuticals Inc.). First filing -, latest -.
In brief
Jill Leversage files SEC Form 4 as director at AUPH (Aurinia Pharmaceuticals Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Jill Leversage has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 21, 2024 | AUPH Aurinia Pharmaceuticals Inc. | AGrant or award Common Shares | +12,135 | $0.00 | $0 | 25,053 | Nov 25, 2024 |
| Nov 21, 2024 | AUPH Aurinia Pharmaceuticals Inc. | AGrant or award Director Stock Option (right to buy)derivative | +18,641 | $0.00 | $0 | 18,641 | Nov 25, 2024 |
Questions about Jill Leversage
Answered from the filings on this page, as of the latest one.
Is Jill Leversage buying or selling?
Jill Leversage has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Jill Leversage's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jill Leversage has 0.
Where does Jill Leversage file Form 4?
Jill Leversage has filed Form 4 at AUPH (Aurinia Pharmaceuticals Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.